$4.83
+0.28 (+6.15%)
Open$4.58
Previous Close$4.55
Day High$4.85
Day Low$4.58
52W High$26.53
52W Low$18.74
Volume—
Avg Volume106.1K
Market Cap207.58M
P/E Ratio52.85
EPS$0.42
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+380.5% upside
Current
$4.83
$4.83
Target
$23.21
$23.21
$16.63
$23.21 avg
$31.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 29.54M | 29.63M | 31.10M |
| Net Income | -1,183,263 | -1,185,756 | -1,130,465 |
| Profit Margin | -4.0% | -4.0% | -3.6% |
| EBITDA | -1,626,848 | -1,569,658 | -1,729,159 |
| Free Cash Flow | -1,111,274 | -1,455,645 | -1,245,008 |
| Rev Growth | +3.0% | +20.7% | -3.6% |
| Debt/Equity | 0.73 | 0.75 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |